Revenue for the third quarter of 2025 was $0, compared with $12.2 million for the same period in 2024. Revenue in 2024 ...

ObesityWeek 2025, held in Atlanta from November 4-7, showcased unprecedented clinical data that signals a fundamental shift in the obesity treatment landscape. The most striking breakthrough at ...

QUBT strengthens its TFLN leadership with a NIST contract and a POET partnership targeting ultra-fast 3.2Tbps data engines.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced at a ...

The Fraunhofer Institute for Photonic Microsystems IPMS in Germany is a leading research institute in the area of spatial light modulators (SLMs), a technology that is of great relevance to Japan’s ...

Established in 2018 with seed funding from SV Health Investors, Sitryx has an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Oxford Science ...

Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response activity tracking ...

A new technical paper titled “Massively parallel and universal approximation of nonlinear functions using diffractive ...

Evotec receives US$ 5 million milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership: Hamburg, Germany Thursday, Novembe ...

Hamburg: Evotec SE has announced that it has received a USD 5 m milestone payment from Bristol Myers Squibb, following the ...